State Street’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-4,536,941
| Closed | -$238M | – | 3959 |
|
|
2020
Q3 | $238M | Sell |
4,536,941
-869,307
| -16% | -$36M | 0.02% | 636 |
|
|
2020
Q2 | $180M | Buy |
5,406,248
+1,012,296
| +23% | +$32.2M | 0.01% | 697 |
|
|
2020
Q1 | $120M | Buy |
4,393,952
+566,369
| +15% | +$15.8M | 0.01% | 771 |
|
|
2019
Q4 | $75.5M | Buy |
3,827,583
+247,082
| +7% | +$3.95M | 0.01% | 1233 |
|
|
2019
Q3 | $46.4M | Sell |
3,580,501
-164,447
| -4% | -$1.99M | ﹤0.01% | 1496 |
|
|
2019
Q2 | $46.6M | Buy |
3,744,948
+5,271
| +0.1% | +$70K | ﹤0.01% | 1531 |
|
|
2019
Q1 | $54.3M | Buy |
3,739,677
+8,734
| +0.2% | +$112K | ﹤0.01% | 1398 |
|
|
2018
Q4 | $41.2M | Buy |
3,730,943
+668,764
| +22% | +$9.31M | ﹤0.01% | 1480 |
|
|
2018
Q3 | $80.5M | Sell |
3,062,179
-376,615
| -11% | -$10.2M | 0.01% | 1223 |
|
|
2018
Q2 | $70.3M | Sell |
3,438,794
-102,852
| -3% | -$2.21M | 0.01% | 1266 |
|
|
2018
Q1 | $64.3M | Buy |
3,541,646
+242,405
| +7% | +$4.04M | 0.01% | 1268 |
|
|
2017
Q4 | $46M | Buy |
3,299,241
+373,823
| +13% | +$5.05M | ﹤0.01% | 1474 |
|
|
2017
Q3 | $54.1M | Buy |
2,925,418
+271,991
| +10% | +$4.55M | ﹤0.01% | 1320 |
|
|
2017
Q2 | $44.8M | Buy |
2,653,427
+197,978
| +8% | +$3.01M | ﹤0.01% | 1428 |
|
|
2017
Q1 | $32.8M | Buy |
2,455,449
+577,504
| +31% | +$9.05M | ﹤0.01% | 1592 |
|
|
2016
Q4 | $28.3M | Buy |
1,877,945
+121,098
| +7% | +$1.6M | ﹤0.01% | 1642 |
|
|
2016
Q3 | $20.5M | Buy |
1,756,847
+148,435
| +9% | +$1.75M | ﹤0.01% | 1755 |
|
|
2016
Q2 | $17.4M | Sell |
1,608,412
-463,256
| -22% | -$4.78M | ﹤0.01% | 1854 |
|
|
2016
Q1 | $19.1M | Buy |
2,071,668
+99,143
| +5% | +$1.07M | ﹤0.01% | 1753 |
|
|
2015
Q4 | $29.3M | Sell |
1,972,525
-435,140
| -18% | -$7.28M | ﹤0.01% | 1466 |
|
|
2015
Q3 | $39.5M | Buy |
2,407,665
+173,833
| +8% | +$3.56M | ﹤0.01% | 1302 |
|
|
2015
Q2 | $51M | Sell |
2,233,832
-153,433
| -6% | -$3.06M | 0.01% | 1250 |
|
|
2015
Q1 | $36.3M | Buy |
2,387,265
+260,930
| +12% | +$3.39M | ﹤0.01% | 1429 |
|
|
2014
Q4 | $25.6M | Sell |
2,126,335
-11,542
| -0.5% | -$132K | ﹤0.01% | 1628 |
|
|
2014
Q3 | $24.2M | Buy |
2,137,877
+185,181
| +9% | +$2.11M | ﹤0.01% | 1600 |
|
|
2014
Q2 | $23.6M | Sell |
1,952,696
-95,324
| -5% | -$1.13M | ﹤0.01% | 1709 |
|
|
2014
Q1 | $23.9M | Buy |
2,048,020
+515,576
| +34% | +$8.73M | ﹤0.01% | 1646 |
|
|
2013
Q4 | $27.1M | Sell |
1,532,444
-477,500
| -24% | -$8.02M | ﹤0.01% | 1538 |
|
|
2013
Q3 | $28.9M | Buy |
2,009,944
+653,283
| +48% | +$10M | ﹤0.01% | 1467 |
|
|
2013
Q2 | $20.4M | Buy |
+1,356,661
| New | +$17.9M | ﹤0.01% | 1619 |
|
State Street's MNTA Position: Q4 2020 in Review
State Street sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 4,536,941 shares — an estimated $238M sold.
State Street first reported a position in MNTA in Q2 2013 and held it in 30 quarters. The position peaked at $238M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- State Street reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- State Street sold 4,536,941 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $238M.
- State Street first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 30 quarters.
- State Street's Momenta Pharmaceuticals, Inc. position peaked at $238M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on State Street's 13F filing for Q4 2020, filed 16 Feb 2021.